SEC Comment Letter 0000000000-24-005878 to GENETIC TECHNOLOGIES LTD (GENE, GNTLF) (CIK 0001166272)
GENETIC TECHNOLOGIES LTD (GENE, GNTLF) (CIK 0001166272)
Date: May 21, 2024 · CIK: 0001166272 · Accession: 0000000000-24-005878
AI Filing Summary & Sentiment
File numbers found in text: 333-279523
Letter
United States securities and exchange commission logo May 21, 2024 Simon Morriss Chief Executive Officer Genetic Technologies Limited 60-66 Hanover Street Fitzroy Victoria 3065 Australia Re:Genetic Technologies Limited Registration Statement on Form F-1 Filed May 20, 2024 File No. 333-279523 Dear Simon Morriss: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Darrin M. Ocasio, Esq.
Show Raw Text
United States securities and exchange commission logo
May 21, 2024
Simon Morriss
Chief Executive Officer
Genetic Technologies Limited
60-66 Hanover Street
Fitzroy
Victoria 3065 Australia
Re:Genetic Technologies Limited
Registration Statement on Form F-1
Filed May 20, 2024
File No. 333-279523
Dear Simon Morriss:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Darrin M. Ocasio, Esq.